Page 13 - Flow Cytometry News Today

Michael Andreeff, MD, PhD, discusses the potential benefits of E-selectin inhibition in the AML tumor microenvironment, data that have contributed to the further development of uproleselan in this population, and additional AML targets under investigation that may broaden the treatment landscape.

/PRNewswire/ -- Providing clinical laboratory testing services and solutions to Federal, State, and Local Government entities and their partners that will...

The first in-human-study of a new immunotherapy that blocks a natural enzyme tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life, researchers say.

/PRNewswire/ -- The "Industrial Microbiological QC Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Type (PCR,...

Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service...

Michael Andreeff, MD, PhD, discusses the rationale for investigating uproleselan plus venetoclax and azacitidine in patients with acute myeloid leukemia.

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, is leading the way to help laboratories prepare for critical upgrades to comply with the new In Vitro Diagnostic Medical Devices Regulation (IVDR), and to clear up confusion for laboratories that will soon be governed by IVDR.

Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "Global Markets and Technologies for Cell and Tissue Analysis" report has been added to ...

A sensitization workshop on ICD 10 coding was organised by the Department of Hospital Administration AIIMS Bhopal in collaboration with Central Bureau of Health Intelligence, regional office Health and family Welfare Government of India in AIIMS Bhopal on Wednesday. The programme was inaugurated

Professor Itaru Hamachi, Lecturer Tomonori Tamura, and Assistant Professor Masaki Tsuchiya of Kyoto University have developed a new technology called O-ClickFC (Organelle-selective click labeling with flow cytometry), which can, at a very high speed, analyze the metabolic state of lipids in cells.